Preclinical Tests Shows Agent Stops “Slippery” Proteins from Binding, Causing Ewing SarcomaSome tumors regressed to the point that cancer cells could not be detected microscopically.
Study IDs Key Protein for Cell DeathFindings may offer a new way to kill cancer cells by forcing them into an alternative programmed-death pathway.
Whole Gel Processing Procedure for GeLC-MS/MS Based ProteomicsThe procedure will enable clinical proteomics for which GeLC-MS/MS is a popular workflow and sample numbers are relatively high.
Spontaneous Mutations Play a Key Role in Congenital Heart DiseaseNew research shows that about 10 percent of these defects are caused by genetic mutations that are absent in the parents of affected children.
Waters Users’ Meeting at ASMS 2013Register for the Waters Users’ meeting at ASMS 2013 and learn about the latest developments in Mass Spectrometry from Waters experts as we reveal our new technologies and solutions.
Thermo Scientific at ASMS 2013Learn how scientists and researchers are transforming science by applying innovative solutions to a wide range of qualitative and quantitative applications.
Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue CultureRapid development of MS-based proteomic techniques in the last decade that has immensely helped researchers in candidate biomarker discovery.
Agilent Technologies Announces Winner of Fifth Annual Early Career Professor AwardAssistant Professor at Northwestern Recognized for Cancer Diagnostics Research.
Gene Discoveries Give Hope Against 'Brittle Bone' DiseaseScientists pinpoint mutation that appears to cause severe forms of bone loss.
Duke Researchers Describe How Breast Cancer Cells Acquire Drug ResistanceA seven-year quest has revealed a previously unknown molecular network that regulates cell death.
